Philips CPAP recall: 20M CAD partial settlement proposed in Canadian class action
By HME News Staff
Updated 10:08 AM CDT, Tue July 22, 2025
VANCOUVER, B.C., and TORONTO – A proposed partial settlement of 20 million CAD has been reached in the Canada-wide class actions against Philips Respironics, addressing economic loss claims related to the recall of certain CPAP, BiPAP and ventilator devices, according to Sotos Class Actions.
The lawsuits—Morel v. Koninklijke Philips N.V. et al. and Roy v. Respironics Inc. et al.—represent individuals, corporations, hospitals and partnerships across Canada who purchased or used affected devices included in the voluntary recall announced in June 2021.
Key details of the proposed settlement:
- Settlement fund: $20 million CAD to compensate for out-of-pocket expenses related to the recall.
- Compensation plan:
- Up to $125 per recalled device.
- 30% to 90% reimbursement of replacement costs (with receipts), minus legal and administrative fees.
- Estimated class size: More than 300,000 affected individuals and entities.
This partial settlement covers only economic losses. Personal injury claims remain active, and class members retain the right to pursue those separately.
The settlement is subject to court approval in British Columbia and Quebec. If approved, all class members who have not opted out will be bound by its terms.
Related U.S. settlement:
In a separate but related settlement, Philips Respironics agreed last year to pay $1.1 billion USD to resolve personal injury and medical monitoring claims in the United States. The company has not admitted any wrongdoing.
Comments